Xing Xiaoyan, Du Xiaojuan, Lu Zheming, Ning Tao, Su Xiulan, Ke Yang
Beijing Institute for Cancer Research, School of Oncology, Peking University, No. 1 Da Hong Luo Chang St., West District, Beijing 100034, P.R. China.
Gene. 2005 Jan 3;344:161-9. doi: 10.1016/j.gene.2004.09.036. Epub 2004 Nov 19.
1A6/DRIM (Down-regulated in Metastasis) has been reported to express at a high level in the gastric cancer tissues and the premalignant lesions implicating the involvement of 1A6/DRIM in cell transformation. Although the information regarding the putative functions and distribution of the 1A6/DRIM in different tissues and cell lines has been increasing recently, its promoter and promoter-regulating factors remain unknown. In this study, the transcription initiation site of 1A6/DRIM was confirmed to be located at 147 bp upstream of the ATG codon using the primer extension analysis. The minimal promoter region of the 1A6/DRIM is located between -47 and +42 of the transcription initiation site measured by luciferase reporter assays using a set of deletion constructs. In addition, an E-box is shown to be an essential element for transcriptional regulation of 1A6/DRIM demonstrated by luciferase assay with different deletion and mutation constructs. Finally, a transcription factor, upstream stimulatory factor 2 (USF2) was found to be an activator of the 1A6/DRIM through binding to the E-box demonstrated by luciferase reporter assay, electrophoretic mobility shift assay, and chromatin immunoprecipitation (ChIP) assay. The structural analysis of the 1A6/DRIM promoter and the identification of its potential regulatory effecter may help us to understand its biological functions in regulating cancer development.
1A6/DRIM(转移下调基因)已被报道在胃癌组织和癌前病变中高表达,这表明1A6/DRIM参与细胞转化。尽管最近关于1A6/DRIM在不同组织和细胞系中的假定功能和分布的信息不断增加,但其启动子和启动子调节因子仍然未知。在本研究中,使用引物延伸分析证实1A6/DRIM的转录起始位点位于ATG密码子上游147 bp处。通过使用一组缺失构建体的荧光素酶报告基因测定,1A6/DRIM的最小启动子区域位于转录起始位点的-47至+42之间。此外,通过使用不同缺失和突变构建体的荧光素酶测定表明,E盒是1A6/DRIM转录调控的必需元件。最后,通过荧光素酶报告基因测定、电泳迁移率变动分析和染色质免疫沉淀(ChIP)测定表明,转录因子上游刺激因子2(USF2)通过与E盒结合而成为1A6/DRIM的激活剂。1A6/DRIM启动子的结构分析及其潜在调节效应物的鉴定可能有助于我们了解其在调节癌症发展中的生物学功能。